Non-viral transfection resulting in healthy and functional cells

At Kytopen, we enable transformative therapies with our patent-pending technology, Flowfect®.  Our cell engineering platforms using this non-viral transfection technology offers the continuous flow of cells to provide a fast, scalable and gentle process.  Using Flowfect® results in billions of high quality transfected cells in minutes while maintaining cell health and function.

Learn More

image-kytopen-300x232
ICO

KYTOPEN enables cell engineering from discovery to manufacturing

ICO

KYTOPEN enables safer and faster therapeutic development

Contact

GET IN TOUCH

Pic Kytopen Team